Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Rules in Favor of Agilent in AP-MALDI Dispute with University of California

NEW YORK, May 18 (GenomeWeb News) - The US Patent and Trademark Office has determined that Agilent Technologies may not have been the first to the patent office, but it did beat the University of California in developing an improved method of mass spectrometry, and therefore deserves a patent for the technology.

Based on the USPTO ruling, "most of the claims" of a University of California patent covering the technology have been canceled, and a patent is expected to be issued "soon" to Agilent, the company said today.

Agilent said that the USPTO's Board of Patent Appeals ruled in its favor in an interference proceeding regarding its 1998 patent application covering atmospheric pressure matrix-assisted laser desorption/ionization (AP-MALDI), a method that permits ionization to take place at atmospheric pressure, eliminating the need for a high vacuum.

The proceeding -- conducted to determine priority of invention between contested patent applications - was held on Feb. 19 to address the dispute between Agilent and the University of California, which also applied for a patent related to AP-MALDI. Although the patent (US Patent 5,965,884) was initially issued to the University of California, the patent office "declared an interference between the University of California patent and the Agilent application because they covered the same inventive subject matter," Agilent said.

Three administrative patent judges awarded priority to Agilent "after evaluating the evidence surrounding the independent inventions of the two parties," Agilent said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.